U.S. Cancer Death Rates Continue To Fall As Lung Cancer Progress Accelerates

For millions of American families, a cancer diagnosis can change life in an instant. Yet new national data released September 22, 2026, offer an encouraging view of the broader fight against the disease. Cancer death rates in the United States continued to decline among both men and women from 2019 through 2023, extending a downward trend that has lasted for more than two decades. A major reason for that progress is the improving outlook for lung cancer, which remains the leading cause of cancer death nationwide.

Lung Cancer Progress Is Driving A Larger Change

The 2026 Annual Report to the Nation on the Status of Cancer examined cancer incidence and mortality across the United States. The report is produced through collaboration among major national cancer and public health organizations, including the Centers for Disease Control and Prevention, National Cancer Institute, American Cancer Society, and North American Association of Central Cancer Registries.

The findings show that overall cancer death rates declined by an average of 1.6 percent per year among males and 1.1 percent per year among females between 2019 and 2023.

Progress against lung cancer was even more pronounced. During the same period, lung cancer death rates decreased by an average of 4.7 percent annually among males and 3 percent annually among females.

Those numbers are especially significant for men. Lung cancer remains the second most commonly diagnosed cancer among both men and women in the United States, and it continues to cause more cancer deaths than any other cancer.

The report also found that lung cancer incidence declined from 2018 through 2022. Rates fell by an average of 3.5 percent per year among males and 1.9 percent among females.

Decades Of Change Are Producing Results

Researchers point to several developments behind the improvement in lung cancer outcomes.

One of the most important has been the long term decline in cigarette smoking. Smoking remains the leading risk factor for lung cancer, and reductions in tobacco use over recent decades have contributed to fewer people developing the disease.

Early detection has also become increasingly important. Finding lung cancer before it has spread can expand treatment options and improve outcomes. The report highlighted substantial growth in the proportion of lung cancers diagnosed at an early stage during the first quarter of this century.

At the same time, advances in cancer treatment have changed what is possible after diagnosis. Modern care can include surgery, radiation, chemotherapy, immunotherapy, and targeted treatments, depending on the type and stage of cancer and the individual patient's circumstances.

Together, prevention, earlier diagnosis, and improved treatment have contributed to a notable change in survival. According to the national report, five year relative survival for lung cancer has approximately doubled during the period examined.

The Broader Cancer Picture Remains Complicated

The encouraging mortality figures do not mean every cancer trend is moving in the same direction.

Researchers examined new cancer cases in the United States from 2003 through 2022. Overall cancer incidence increased slightly from 2018 through 2022, driven in part by rising rates of breast cancer among women and prostate cancer among men.

Prostate cancer remains the most commonly diagnosed cancer among American men. Although prostate cancer incidence increased, the overall rate of new cancer cases among males remained stable.

The combination of rising incidence for certain cancers and declining overall mortality highlights an important distinction. The number of people diagnosed with cancer and the number who die from it do not necessarily move together. Changes in risk factors, screening practices, detection, treatment, and population demographics can influence these trends differently.

What Men Should Know About Lung Cancer Risk

For men, the new findings reinforce the importance of understanding personal risk rather than assuming lung cancer is only a concern later in life.

Smoking history remains particularly important. However, lung cancer can also occur in people who have never smoked. Other recognized risk factors include exposure to secondhand smoke, radon, and certain workplace substances.

Screening recommendations are designed for people at elevated risk rather than the general population. Adults who are concerned about their personal risk can discuss their health history and current screening guidelines with a qualified healthcare professional.

Symptoms such as a persistent cough can have many possible causes and do not automatically indicate cancer. Still, persistent or concerning health changes deserve appropriate medical attention.

A Health Trend Worth Watching

The latest national figures provide measurable evidence that progress against cancer can accumulate over decades. Lower smoking rates, earlier detection, and advances in treatment have helped push lung cancer mortality downward, contributing to a broader decline in U.S. cancer deaths.

At the same time, lung cancer remains the country's leading cause of cancer death, while changing incidence patterns for other cancers show why continued monitoring matters.

For American men, the most useful takeaway is straightforward: understanding personal risk, avoiding tobacco exposure, paying attention to lasting health changes, and discussing appropriate preventive care with a healthcare professional remain practical parts of long term health management. The new numbers offer encouraging evidence of progress, but they also show why cancer prevention and early detection continue to matter.